FDA recall D-1494-2020

PAI Holdings, LLC. dba Pharmaceutical Associates Inc · Class II · drug

Product

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16

Reason for recall

Subpotent drug: Out of specification for assay at the 15-month test interval.

Distribution

Nationwide USA

Key facts

Status
Terminated
Initiation date
2020-08-04
Report date
2020-08-19
Termination date
2021-09-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Greenville, SC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1494-2020